![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears DiaSorin Molecular’s VZV Assay
FDA Clears DiaSorin Molecular’s VZV Assay
June 3, 2019
DiaSorin Molecular has nabbed the FDA’s clearance for its Simplexa VZV Direct assay, a molecular diagnostic test used to detect the varicella-zoster virus (VZV).
The diagnostic—which is meant to be used alongside the company’s HSV 1 and 2 direct assay—is used with samples of cerebrospinal fluid to detect virus DNA, making it effective in the diagnosis of meningitis and encephalitis.
VZV causes varicella (chickenpox), a highly transmissible disease most commonly experienced in early childhood that can cause acute meningitis.
Upcoming Events
-
21Oct